Ikigai Corporation

Ikigai Bio is a San Diego-based biotechnology company dedicated to the development of programmable genetic medicines. The company's platform focuses on non-viral delivery systems designed to provide safer, more redosable, and more accessible genetic therapies compared to traditional viral vector approaches. By integrating advanced computational design with novel delivery chemistry, Ikigai Bio aims to address a wide spectrum of genetic disorders. The company is currently operating in a pre-clinical phase, building a pipeline of internal candidates while refining its core technology. Led by industry veterans from Genentech, the firm seeks to overcome the current limitations of gene therapy through precision engineering.